Emil Natanson Nachman is a litigation associate in the New York office of Gibson Dunn. His practice focuses on patent litigation in the biotechnology and pharmaceutical industries. He has represented and advised clients in high-value patent matters covering a broad variety of technologies, including small molecules, immunotherapies, small RNAs, mRNA vaccines, next-generation sequencing, and agricultural genetics. He has litigated administrative proceedings, District Court trials, preliminary injunctions, and temporary restraining orders, and Federal Circuit Appeals. Before law school Emil was a student in molecular genetics, focusing on the role of alternative splicing in regulating gene expression and cell identity. Emil received his Juris Doctor from Harvard Law School, and a Master of Science in Molecular Genetics and a Bachelor of Science in Molecular and Cell Biology from the University of Toronto.
Representative Matters
- Novartis Pharmaceuticals Corp.: Hatch-Waxman litigations regarding first oral therapy for multiple sclerosis
- Moderna, Inc.: patent infringement litigation regarding lipid nanoparticles for mRNA vaccines
- Confidential client: pre-litigation advice to top-10 biopharmaceutical company for BPCIA litigation over leading multi-indication biologic associated with large patent portfolio
- Guardant Health, Inc.: trade secret litigation regarding next-generation sequencing-based cancer diagnostic
- Novartis Pharmaceuticals Corp.: Hatch-Waxman and trade secret litigation regarding first-in-class radioligand therapy for neuroendocrine tumors
- Gilead Sciences, Inc.: Hatch-Waxman litigation regarding breakthrough single-tablet-regimen HIV treatment
- Confidential client: analysis of patents regarding siRNA therapy for acute macular degeneration
Publications
- Co-Author, Han, et al. "MBNL proteins repress ES-cell-specific alternative splicing and reprogramming." Nature 498.7453 (2013): 241-245
- Co-Author, Braunschweig, et al. "Widespread intron retention in mammals functionally tunes transcriptomes." Genome Research 24.11 (2014): 1774-1786
Capabilities
Credentials
Education:
- Harvard University - 2018 Juris Doctor
- University of Toronto - 2015 Master of Science
- University of Toronto - 2012 Bachelor of Science
Admissions:
- New York Bar